LICORDARI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 622
NA - Nord America 535
AS - Asia 179
SA - Sud America 12
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.351
Nazione #
US - Stati Uniti d'America 531
IE - Irlanda 217
IT - Italia 156
SE - Svezia 126
SG - Singapore 123
FI - Finlandia 43
DE - Germania 36
IN - India 26
CN - Cina 21
AT - Austria 15
GB - Regno Unito 9
HK - Hong Kong 7
CL - Cile 5
BR - Brasile 4
CA - Canada 4
NL - Olanda 4
BE - Belgio 3
FR - Francia 3
CZ - Repubblica Ceca 2
LT - Lituania 2
RU - Federazione Russa 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
CH - Svizzera 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
LK - Sri Lanka 1
MA - Marocco 1
NO - Norvegia 1
SA - Arabia Saudita 1
Totale 1.351
Città #
Dublin 217
Chandler 115
Singapore 104
Ashburn 92
Nyköping 76
New York 45
Helsinki 37
Messina 35
Munich 29
Pune 19
Princeton 18
Medford 17
Vienna 15
Los Angeles 12
Catania 11
Rome 9
Boardman 8
Des Moines 8
London 8
Hyderabad 6
Beijing 5
Bremen 5
Chicago 5
Espoo 4
Petrosino 4
Porto Alegre 4
Seattle 4
Amsterdam 3
Bologna 3
Brussels 3
Citta 3
Florence 3
Gravina di Catania 3
Milan 3
Nanchang 3
Sciacca 3
Washington 3
Zumpano 3
Bisignano 2
Cagliari 2
Gela 2
Guangzhou 2
Lappeenranta 2
Moscow 2
Ottawa 2
Palermo 2
Redwood City 2
San Marcellino 2
Turin 2
Wilmington 2
Albuquerque 1
Belvedere Spinello 1
Bogotá 1
Brno 1
Cairo 1
Castelnuovo Rangone 1
Colombo 1
Frankfurt am Main 1
Fuzhou 1
Guayaquil 1
Hong Kong 1
Jinan 1
Lanzhou 1
Lyon 1
Magdeburg 1
Meppel 1
Montecorice 1
Nanning 1
Olomouc 1
Paris 1
Piazza Armerina 1
Puerto Eldorado 1
Riyadh 1
Santa Clara 1
Santa Venerina 1
Shenyang 1
Springfield 1
Strasbourg 1
Taiyuan 1
Tianjin 1
Wenzhou 1
Zhengzhou 1
Zurich 1
Totale 1.002
Nome #
Atrial fibrillation and thrombophilia. DOAC as a valid alternative? A clinical case 92
Comparison of new myocardial work indexes and others left ventricle sistolic function parameters in ischaemic patients 79
Takotsubo syndrome: prognostic predictors 66
Analysis of multilayer strain and myocardial work in patients undergoing chemotherapy treatment: a 12 months follow-up 65
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 60
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 55
Ruolo dell'intervello PPI post ATP fallito nella discriminazione degli ICD 54
Cardiac and Vascular Impairment in Patients with Mild Psoriasis: A Longitudinal Study 51
Bicuspid aortic valve and aortopathy: novel prognostic predictors for the identification of high-risk patients 50
Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis 48
Non-invasive assessment of myocardial work: an useful tool for predicting LV remodelling after myocardial infarction? 47
Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis 44
An “ordinary” case of COVID-19 pneumonia: when symptoms hide serious complications 42
62 MYOCARDIAL WORK IN CARDIAC AMYLOIDOSIS AND HYPERTENSIVE HEART DISEASE: A PRELIMINARY REPORT 41
Prognostic value of two-dimensional strain in early ischemic heart disease: A 5-year follow-up study 39
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 39
QTC CORRECTION IN ATRIAL FIBRILLATION 38
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 36
PROGNOSTIC VALUE OF TWO DIMENSIONAL STRAIN IN EARLY ISCHEMIC HEART DISEASE: A 5-YEAR FOLLOW-UP STUDY 30
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 30
SCREENING FOR ANDERSON-FABRY DISEASE IN RELATIVELY YOUNG PATIENTS WITH UNEXPLAINED CONDUCTION DISORDERS REQUIRING PACEMAKER IMPLANTATION 30
The High Bleeding Risk Patient with Coronary Artery Disease 29
DAPAGLIFOZIN AND PULMONARY PRESSURES IN HFREF: A NON INVASIVE ASSESSMENT 28
Assessment of Intra and Extra-Hospital Outcome after Takotsubo Syndrome in a Single-Center Population 27
Echocardiographic Patterns of Abnormal Septal Motion: Beyond Myocardial Ischemia 26
null 26
Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study 25
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 23
Lipomatous Hypertrophy of the Interatrial Septum: A Case Report and Insights from the Literature 22
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 20
Atrial Fibrillation and QT corrected. What is the best formula to use? 17
Advanced echocardiographic analysis to identify cardiac toxicity after TKI exposure in patients with CML 17
Anthracyclines therapy and regional myocardial damage in breast cancer patients: how, when and where? 13
null 13
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management 11
Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonance 11
Incidence of acute myocarditis and pericarditis during the coronavirus disease 2019 pandemic: comparison with the prepandemic period 10
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 10
The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population 9
RISK STRATIFICATION AND PREDICTORS OF OUTCOME IN ASYMPTOMATIC AORTIC STENOSIS: THE ROLE OF MULTIMODALITY IMAGING 9
Multimodality imaging to assess severity and outcome in asymptomatic patients with aortic stenosis: a medium-long term follow-up study 9
Arrhythmic risk profile in mitral valve prolapse: A systematic review and metanalysis of 1715 patients 8
Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management—A Narrative Review 7
Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update 7
Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers 6
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 6
Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction 6
Clinical Applications of Myocardial Work in Echocardiography: A Comprehensive Review 5
Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure 4
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 2
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations 2
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation 2
Totale 1.446
Categoria #
all - tutte 8.888
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.888


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 4 0 0
2020/202168 0 0 4 15 11 12 15 4 1 2 4 0
2021/2022142 0 6 11 1 3 1 8 5 8 46 1 52
2022/2023588 27 48 17 25 26 82 16 44 261 11 21 10
2023/2024339 14 35 9 33 29 102 52 17 5 13 2 28
2024/2025305 18 27 11 104 81 64 0 0 0 0 0 0
Totale 1.446